AstraZeneca's COVID-19 vaccine will go before the World Health Organization's vaccine advisory panel for a review scheduled for Feb. 8. The date is tentative, according to Joachim Hombach, executive secretary of WHO's Strategic Advisory Group of Experts on Immunization.